Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.
Steve OrmeRichard J Q McNallyPeter W JamesJessica DavisJohn AyukClaire E HighamJohn Wassnull nullPublished in: Clinical endocrinology (2024)
Acromegaly is associated with increased incidence of all cancers but not thyroid or colon cancer and no increase in cancer mortality. Excess mortality is due to vascular and respiratory disease. The risk is highest in the first 5 years following diagnosis and is mitigated by normalising GH levels.